Elephas Biosciences
PrivateLast Round
Series B
Extension
Nov 6, 2025
Total Funding Raised
$212.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Elephas Biosciences is a biotechnology company that develops a precision oncology platform utilizing artificial intelligence and advanced 3D imaging to test live patient tumor biopsies against potential therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elephas Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Elephas Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Nov 6, 2025 | ||||
| Series C | Jan 23, 2024 | ||||
| Series B | Sep 6, 2022 | ||||
| Series A | Oct 14, 2021 | ||||
| Series A | Sep 15, 2021 | ||||
Seed | Apr 1, 2020 |
Key People
Founding team and executive leadership
Elephas Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARCH Venture Partners | Series B Extension, Series C, Series B |
| WARF Ventures | Series A, Series C, Series B |
| State of Wisconsin Investment Board | Series B Extension, Series C |
| Northpond Ventures | Series B Extension, Series C, Series B |
| Moore Strategic Ventures | Series C, Series B |
| Venture Investors Health Fund | Series B Extension, Series C |
| ARCH Venture Partners | Series B Extension, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Partnering with Mithrl to accelerate research using their AI platform.
- Feb 1, 2026
Partnering with the University of Louisville on cancer therapy research.
Elephas Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elephas Biosciences's valuation, stock price, and market status.